Exosens revenue and financials
€56.65Change from previous close: −7.28%Absolute change: −€4.45
In the fiscal year ended December 2025, Exosens reported revenue of €383.4M (−18.11% year over year). Net income was €30.7M, a net margin of 8.0%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- −18.11%
- 2025 vs 2024
- Net income growth
- −28.10%
- 2025 vs 2024
- Net margin
- 8.0%
- 2024: 9.1%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | 107 | 98.8 | 50.5 | 47.5 | — |
| Depreciation and amortization | 39.5 | 34.6 | 30.9 | — | — |
| Capital expenditure | — | — | -30.9 | -21.8 | — |
| Investing cash flow | -121 | -71.4 | -99.6 | -55.5 | — |
| Financing cash flow | -25.2 | 76.9 | 35.5 | 20.3 | — |
| Dividends paid | -5.1 | 0.0 | — | — | — |
| Share repurchases | -8.8 | -0.3 | 0.0 | — | — |
| Debt issued | — | — | 65.1 | 40.0 | 213 |
| Debt repaid | — | — | -5.4 | -3.1 | -271 |
| Effect of exchange rates | -0.8 | 0.4 | 0.2 | 0.1 | — |
| Net change in cash | -46.4 | 99.9 | -13.7 | 12.3 | — |
| Free cash flow | 107 | 98.8 | 50.5 | 25.7 | — |